Post-Series A, the board expects execution on the EU expansion plan. The first question from the lead investor is not about sales pipelines — it is about regulatory risk. European regulations that can block market access or create financial liability. Regulation (EU) 2024/2847 is the newest one. Article 64 penalties of up to €15 million or 2.5% of worldwide annual turnover. Article 2(1) applies from the moment you place your product on the EU market. The investor does not need a 50-page regulatory readiness report. They need to see that you have assessed the CRA and produced the documentation. CRACheck generates 8 PDF documents under Art. 31 + Annex VII in 15–25 minutes. €149. 100% browser-side. Board-ready artefact.
€149 one-time · 8-document ZIP · 15–25 minutes · Browser-side
Article 2(1) of Regulation (EU) 2024/2847 applies from the moment you make your product available on the EU market. Article 13(12) requires technical documentation before market placement. There is no "product-market fit first, compliance later" path. The documentation must exist before the first EU customer.
Article 64(5)(c) of Regulation (EU) 2024/2847 requires authorities to consider the "size, in particular with regard to microenterprises and small and medium sized-enterprises, including start-ups." The fine may be adjusted for startup size — but the obligation exists regardless. And the reputational damage of non-compliance in front of EU enterprise clients matters more than the fine.
A European compliance firm charges €15,000–€25,000 for a regulatory readiness assessment. At Series A, that is 3–5% of the round. CRACheck costs €149 — and produces the actual Annex VII documentation, not just a readiness report. The Series B budget can go to market expansion instead of regulatory assessment.
8 PDF documents generated from your data. Each cites the specific article of Regulation (EU) 2024/2847 it complies with.
Classification under Annex III/IV. Board-visible: the product is classified, the conformity path is identified.
Annex VII. The core compliance artefact.
Art. 13(2). Product-specific cybersecurity risk assessment.
Annex II. Ready for EU customer onboarding documentation.
Art. 28 + Annex V. Manufacturer declaration.
Annex I Part II §5. Vulnerability disclosure process.
Art. 14. ENISA notification from Sept 2026. Art. 14(2): early warning within 24h, notification within 72h, final report within 14 days.
Key dates aligned with the startup's expansion timeline.
Mira antes de comprar — Descargar dossier de muestra (PDF, empresa ficticia) — Estructura real, artículos reales, formato real. Datos ficticios.
Generated from your data, in your browser. No data leaves your device.
Generates Annex VII documentation for your product. 8 PDFs. 15 minutes. €149. Board-ready proof of CRA compliance readiness.
Does not produce a comprehensive regulatory risk assessment covering GDPR, AI Act, and other EU regulations. Does not advise on EU market entry strategy. Does not replace legal counsel for fundraising due diligence.
We produce the CRA documentation. You handle the broader EU regulatory landscape.
Article 64 of Regulation (EU) 2024/2847.
Art. 64(2). The percentage-of-turnover metric scales with your growth.
Art. 64(3).
Art. 64(4).
| Alternative | Cost | What you get |
|---|---|---|
| European regulatory readiness assessment | €15,000–€25,000 | Report on regulatory landscape. 3–4 months. No documentation. |
| Hire a compliance officer | ₹25–40 lakh/year | Ongoing cost. 6 months to hire and onboard. |
| "We will figure it out later" | €0 | Board loses confidence. Due diligence flag for Series B. |
| CRACheck | €149 | 8 documents. 15 min. Documentation exists. Board satisfied. |
Each product needs its own Annex VII dossier. If your EU expansion plan covers 2–5 products, generate all dossiers before the board meeting. Contact us for startup volume pricing.
Request Volume PricingCRACheck generates a structured document under Article 31 and Annex VII of Regulation (EU) 2024/2847 from the information you provide. The accuracy is your responsibility as the manufacturer.
We guarantee structure and legal references. We do not guarantee acceptance by a market surveillance authority or by an investor's due diligence team.
CRACheck is not legal advice. For comprehensive EU market entry regulatory strategy, consult a qualified lawyer or regulatory consultancy.
Eight documents. Annex VII fully structured. Regulation (EU) 2024/2847. Your data stays on your device. The ZIP you download is yours forever.